Skip to main content

Conditions & Diseases

More in Conditions & Diseases

Cancer InterceptionExplainer

Experimental KRAS Vaccine Shows Early Promise in Preventing Pancreatic Cancer

Preventative Oncologists 40%Immunology Researchers 35%Clinical Trial Methodologists 25%

7 sources · 28d ago

Prostate CancerTreatment Explainer

FDA Approves First Radioligand Therapy for Hormone-Sensitive Metastatic Prostate Cancer in Major Oncology Shift

Oncology Specialists 41%Patient Advocacy Groups 29%Industry & Market Analysts 29%

8 sources · 36d ago

Cholesterol CareMedical Breakthrough

FDA Approves First Oral PCSK9 Inhibitor to Lower Cholesterol, Offering Alternative to Injectables

Cardiologists & Lipid Specialists 40%Patient Advocacy Groups 30%Industry Analysts 30%

7 sources · 41d ago

ExplainerRespiratory Health

FDA Approves Ohtuvayre, the First COPD Drug with a Novel Mechanism in Over Two Decades

Clinical Researchers 40%Patient Advocates 30%Regulatory & Industry Analysts 30%

4 sources · 72d ago

ExplainerCeliac Pipeline

The Evidence Pack: How New Therapies Are Moving Celiac Disease Beyond the Gluten-Free Diet

Clinical Researchers 35%Patient Advocates 35%Factlen Editorial 30%

2 sources · 74d ago

ExplainerChronic Pain

The Evidence Pack: How Pain Reprocessing Therapy is Rewiring the Brain to Eliminate Chronic Pain

Neuroscience Researchers 40%Mind-Body Practitioners 35%Traditional Pain Specialists 25%

5 sources · 75d ago

EndometriosisMedical Breakthrough

The Evidence Pack: How Precision Peptides and Urine Tests Are Rewriting Endometriosis Care

Biotech Innovators 41%Diagnostic Researchers 35%Clinical Specialists 24%

4 sources · 75d ago

Cancer ScreeningExplainer

The Blood Test That Could Change Cancer Screening: What to Know About MCEDs

Test Developers & Advocates 45%Cautious Clinical Researchers 40%Regulatory & Policy Watchdogs 15%

6 sources · 77d ago

Organ TransplantationMedical Breakthrough

One Year Later: The World's First Bladder Transplant Patient is Thriving

Surgical Innovators 35%Clinical Researchers 35%Patient Advocates 30%

5 sources · 74d ago

Antibiotic ResistanceExplainer

FDA Approves Utebzi as First Oral Carbapenem Antibiotic for Complicated UTIs

Infectious Disease Specialists 35%Patients and Caregivers 35%Healthcare Economists 30%

6 sources · 56d ago

ExplainerCardiovascular Health

How COVID-19 Vaccination Protects the Heart: New Data Shows 38% Drop in Major Cardiac Events

Clinical Researchers 45%Public Health Officials 30%Practicing Cardiologists 25%

5 sources · 82d ago

Oncology InnovationExplainer

How mRNA Cancer Vaccines Work: The 5-Year Data Changing Oncology

Clinical Oncologists 45%Biopharma Manufacturers 35%Policy Skeptics 20%

3 sources · 92d ago